Consolidated figures · ₹ crore
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 3,367 | 4,577 | 5,300 | 6,492 | 7,666 | 7,978 | 6,714 | |
| COGS | 1,847 | 2,571 | 2,923 | 3,553 | 3,838 | 3,771 | 2,833 |
| Gross profit | 1,519 | 2,006 | 2,377 | 2,939 | 3,828 | 4,207 | 3,880 |
| 801 | 989 | 1,231 | 1,390 | 1,803 | 2,023 | 2,175 | |
| 719 | 1,017 | 1,146 | 1,549 | 2,025 | 2,183 | 1,705 | |
| OPM % | 21.4% | 22.2% | 21.6% | 23.9% | 26.4% | 27.4% | 25.4% |
| Depreciation | 137 | 175 | 202 | 227 | 308 | 353 | 407 |
| Interest | 17 | 28 | 13 | 37 | 30 | 33 | 16 |
| 49 | 125 | 101 | 159 | 208 | 344 | 414 | |
| Profit before tax | 614 | 939 | 1,033 | 1,444 | 1,895 | 2,142 | 1,696 |
| Tax | 157 | 200 | 189 | 215 | 213 | 482 | 375 |
| Tax % | 25.6% | 21.3% | 18.3% | 14.9% | 11.3% | 22.5% | 22.1% |
| 457 | 738 | 844 | 1,230 | 1,682 | 1,660 | 1,321 | |
| PAT margin % | 13.6% | 16.1% | 15.9% | 18.9% | 21.9% | 20.8% | 19.7% |
| EPS (₹) | 33.1 | 49.9 | 55.7 | 81.1 | 110.9 | 109.4 | 87.1 |
| EPS adjusted (₹) | 29.1 | 53.2 | 55.5 | 80.9 | 110.6 | 108.5 | 85.6 |
| 12.1% | 10% | 10.8% | 12.3% | 13.5% | 14.6% | 17.2% | |
| Annual report | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 14 | 14 | 14 | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 1,911 | 2,272 | 2,605 | 5,327 | 6,105 | 7,183 | 8,716 | 10,142 | 11,215 |
| 46 | 10 | 508 | 257 | 268 | 0 | 128 | 112 | 238 | |
| 655 | 860 | 1,098 | 1,402 | 1,403 | 1,281 | 1,905 | 2,008 | 1,975 | |
| Total equity & liabilities | 2,626 | 3,155 | 4,225 | 7,002 | 7,791 | 8,480 | 10,764 | 12,277 | 13,444 |
| 998 | 1,186 | 1,858 | 2,138 | 2,453 | 2,606 | 3,528 | 4,209 | 4,620 | |
| CWIP | 69 | 154 | 237 | 250 | 64 | 63 | 173 | 384 | 755 |
| Investments | 161 | 129 | 150 | 729 | 900 | 1,016 | 1,336 | 1,531 | 1,360 |
| 1,399 | 1,686 | 1,980 | 3,886 | 4,375 | 4,796 | 5,726 | 6,153 | 6,709 | |
| Total assets | 2,626 | 3,155 | 4,225 | 7,002 | 7,791 | 8,480 | 10,764 | 12,277 | 13,444 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Agro Chemicals | 6,416.8 | 1,797.5 | 11,973.6 | 1,811.5 | 10,162.1 | 17.69 |
| Pharma | 300.5 | -274.4 |
| ₹ Cr | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 319 | 391 | 698 | 725 | 529 | 1,501 | 2,036 | 1,413 | 474 | |
| -181 | -322 | -985 | -2,430 | -110 | -496 | -1,801 | -1,424 | -614 | |
| -106 | -125 | 350 | 1,690 | -177 | -483 | -222 | -287 | -171 | |
| Net cash flow | 33 | -56 | 63 | -15 | 241 | 522 | 14 | -298 | -311 |
| Free cash flow | — | — | 24 | 286 | 192 | 1,175 | 1,416 | 563 | -644 |
| CFO / Operating profit % | — | — | 97.3% | 71.6% | 46.3% | 97.4% | 101.1% | 64.9% | 27.9% |
| 1,470.1 |
| 401.7 |
| 1,068.4 |
| -25.68 |
| Inter segment adjustment | 0 | 69.9 | 0 | 0 | — | — |
₹ crore by fiscal year